Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AMRI Consolidates Drug Discovery Platform | Contract Pharma
Breaking News

AMRI Consolidates Drug Discovery Platform

AMRI has merged its Discovery R&D and Discovery Chemistry departments to form a Global Drug Discovery organization.

AMRI has merged its Discovery R&D and Discovery Chemistry departments to form a Global Drug Discovery organization. Bruce J. Sargent, Ph.D., has been appointed senior vice president of the new organization. The company is combining its discovery chemistry and biology functions into a single unit across locations worldwide.

“AMRI has been involved in numerous integrated discovery projects for a number of years,” said Dr. Sargent. “Our experience in successfully developing projects both internally and in collaboration with customers stands as a testament to our ability to provide a high level of project management, well developed and tested solutions, and added-value to our customers.”

“Customers are increasingly seeking out CROs that can provide them with fully integrated solutions in their pursuit to diminish costs and project timelines, while still desiring to maintain a high level of quality and value,” said chairman, chief executive officer and president Thomas E. D’Ambra, Ph.D. “We believe that combining all of our discovery capabilities in biology and discovery chemistry under the direction of Dr. Sargent will further enhance AMRI’s ability to generate significant value for our customers and stakeholders.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters